Drug Shortage Report for TIAZAC XC
Report ID | 64999 |
Drug Identification Number | 02256738 |
Brand name | TIAZAC XC |
Common or Proper name | TIAZAC XC |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 120MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 90 |
ATC code | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2018-10-31 |
Actual start date | |
Estimated end date | |
Actual end date | 2018-11-07 |
Shortage status | Resolved |
Updated date | 2018-11-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-11-09 | French | Compare |
v4 | 2018-11-09 | English | Compare |
v3 | 2018-11-01 | English | Compare |
v2 | 2018-10-19 | French | Compare |
v1 | 2018-10-19 | English | Compare |
Showing 1 to 5 of 5